Thymidylate synthase is a predictor for response and resistance in hepatic artery infusion chemotherapy

Cancer Letters

Volumn 118, Issue 1, 1997, Pages 29-35

  Kornmann, Marko ^a   Link, Karl H ^a   Lenz, Heinz Josef ^b   Pillasch, Jürgen ^a   Metzger, Ralf ^b   Butzer, Urwe ^a   Leder, Gerhard H ^a   Weindel, Marlen ^a   Safi, Farouk ^a   Danenberg, Kathleen D ^b   Beger, Hans G ^a   Danenberg, Peter V ^b  

^a UNIVERSITY OF ULM   (Germany)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Chemosensitivity; Chemotherapy; Colorectal cancer; Hepatic artery infusion; Predictive parameter; Thymidylate synthase

Indexed keywords

CISPLATIN; EPIRUBICIN; FLOXURIDINE; FLUOROURACIL; FOLINATE CALCIUM; MESSENGER RNA; MITOMYCIN C; MITOXANTRONE; THYMIDYLATE SYNTHASE;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RESISTANCE; CANCER SURVIVAL; CLINICAL ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; DRUG RESISTANCE; DRUG RESPONSE; FEMALE; GENE EXPRESSION; HEPATIC ARTERY; HUMAN; HUMAN TISSUE; INTRAARTERIAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LIVER METASTASIS; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE LEVEL;

ADULT; AGED; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BIOLOGICAL MARKERS; COLORECTAL NEOPLASMS; DRUG ADMINISTRATION SCHEDULE; DRUG RESISTANCE, NEOPLASM; EPIRUBICIN; FEMALE; FLOXURIDINE; FLUOROURACIL; HEPATIC ARTERY; HUMANS; INFUSIONS, INTRA-ARTERIAL; LEUCOVORIN; LIVER NEOPLASMS; MALE; MIDDLE AGED; MITOXANTRONE; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RNA, MESSENGER; SURVIVAL RATE; THYMIDYLATE SYNTHASE; TRANSCRIPTION, GENETIC;

EID: 0345973521     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(97)00220-6     Document Type: Article

References (20)

1. E. Busch, M.M. Kemeny, Colorectal cancer; hepatic-directed therapy: the role of surgery, regional chemotherapy, and novel modalities, Semin. Oncol. 22 (1995) 494-508.
2. S. Fujimoto, M. Miyazaki, Y. Kitsukawa, M. Higuchi, K. Okui, Long-term survivors of colorectal cancer with unresectable hepatic metastases, Dis. Colon Rect. 28 (1985) 588-591.
3. T. Horikoshi, K.D. Danenberg, T.H.W. Stadibauer, M. Volkenandt, L.C.C. Shea, K. Aigner, B. Gustavsson, L. Leichman, R. Frösing, M. Ray, N.W. Gibson, C.P. Spears, P.V. Danenberg, Quantitation of thymidylate synthase, dihydrofolate reductase, and DT-diaphorase gene expression in human tumors using the polymerase chain reaction, Cancer Res. 52 (1992) 108-116.
4. P.G. Johnston, C.J. Allegra, Colorectal cancer biology: clinical implications, Semin. Oncol. 22 (1995) 418-432.
5. P.G. Johnston, E.R. Fisher, H.E. Rockette, B. Fisher, N. Wolmark, J.C. Drake, B.A. Chabner, C.J. Allegra, The role of thymidylate synthase expression in the prognosis and outcome of adjuvant chemotherapy in patients with rectal cancer, J. Clin. Oncol. 12 (1994) 2640-2647.
6. L. Leichman, H.-J. Lenz, C.G. Leichman, S. Groshen, K. Danenberg, J. Baranda, C.P. Spears, W. Boswell, H. Silberman, A. Ortega, S. Stain, R. Beart, P. Danenberg, Quantitation of intratumoral thymidylate synthase expression predicts for resistance to protracted infusion of 5-fluorouracil and weekly leucovorin in disseminated colorectal cancers: preliminary report from an ongoing trial, Eur. J. Cancer 31A (1995) 1306-1310.
7. H.-J. Lenz, K.D. Danenberg, C.G. Leichman, K. Hayashi, R. Metzger, D. Salonga, V. Kortes, D. Banerjee, J.R. Bertino, S. Groshen, L. Leichman, P.V. Danenberg, p53 status and thymidylate synthase levels are predictors of chemotherapy efficacy in patients with advanced colorectal cancer, Proc. Am. Soc. Clin. Oncol. 15 (1996) 216.
8. H.-J. Lenz, C.G. Leichman, K.D. Danenberg, P.V. Danenberg, S. Groshen, H. Cohen, L. Laine, P. Crooks, H. Silberman, J. Baranda, Y. Garcia, J. Li, L. Leichman, Thymidylate synthase mRNA level in adenocarcinoma of the stomach: a predictor for primary tumor response and overall survival, J. Clin. Oncol. 14 (1996) 176-182.
9. K.H. Link, M. Kornmann, G.H. Leder, U. Butzer, J. Pillasch, L. Staib, F. Gansauge, H.G. Beger, Regional chemotherapy directed by individual chemosensitivity testing in vitro: a prospective decision-aiding trial, Clin. Cancer Res. 2 (1996) 1469-1474.
10. K.H. Link, E.D. Kreuser, F. Safi, J. Ullrich, A. Schalhorn, E. Schmoll, H.G. Beger, Die intraarterielle Chemotherapie mit 5-FU und Folinsäure (LV, Rescuvolin) im Therapiekonzept bei nicht resektablen kolorektalen Lebermetastasen, Tumordiagn. Ther. 14 (1993) 224-231.
11. S. Lowe, S. Bodis, A. McClatchey, L. Remingtion, H.E. Ruley, D.E. Fisher, D.E. Housman, T. Jacks, p53 status and the efficacy of cancer therapy in vivo, Science 266 (1994) 807-810.
12. A.B. Miller, B. Hoogstraten, M. Staquet, A. Winkler, Reporting results of cancer treatment, Cancer 47 (1998) 207-214.
13. Y. Nabeya, F. Loganzo, P. Maslak, L. Lai, A.R. De Oliveira, G.K. Schwartz, M.L. Blundell, N.K. Altorki, D.P. Kelsen, A.P. Albino, The mutational status of p53 protein in gastric and esophageal adenocarcinoma cell lines predicts sensitivity to chemotherapeutic agents, Int. J. Cancer 64 (1995) 37-46.
14. S.L. Parker, T. Tong, S. Bolden, P.A. Wingo, Cancer Statistics, 1997, CA Cancer J. Clin. 47 (1997) 5-27.
15. G.J. Peters, C.L. Van der Wilt, C.J. Van Groeningen, K. Smid, S. Meijer, H.M. Pinedo, Thymidylate synthase inhibition after administration of fluorouracil with or without leucovorin in colon cancer patients: implications for treatment with fluorouracil, J. Clin. Oncol. 12 (1994) 2035-2042.
16. V. Rusch, D. Klimstra, E. Venkatraman, J. Oliver, N. Martini, R. Gralla, M. Kris, E. Dmitrovsky, Aberrant p53 expression predicts clinical resistance to cisplatin-based chemotherapy in locally advanced non-small cell lung cancer, Cancer Res. 55 (1995) 5038-5042.
17. F. Safi, R. Bittner, R. Roscher, K. Schumacher, W. Gaus, H.G. Beger, Regional chemotherapy for hepatic metastases of colorectal carcinoma (continuous intraarterial versus continuous intraarterial/intravenous therapy), Cancer 64 (1989) 379-387.
18. D.V. Santi, C.S. McHenry, H. Sommer, Mechanism of interaction of thymidylate synthetase with 5-fluorodeoxyuridylate, Biochemistry 13 (1974) 471-481.
19. A.L. Vahrmeijer, J.H. van Dierendonck, C.J.H. van de Velde, Treatment of colorectal cancer metastases confined to the liver, Eur. J. Cancer 31A (1995) 1238-1242.
20. E. Wattel, C. Preudhomme, B. Hecquet, M. Vimrumbeke, B. Quesnel, I. Dervite, P. Morel, P. Fenaux, p53 mutations are associated with resistance to chemotherapy and short survival in hematologic malignancies, Blood 84 (1994) 3148-3157.